(Q33703846)

28 July 2017

1 reference

title

Raloxifene, a new selective estrogen receptor modulator (English)

1 reference

28 July 2017

Goldfrank D

1

1 reference

28 July 2017

Haytoglu T

series ordinal

2

1 reference

28 July 2017

Frishman WH

series ordinal

3

1 reference

28 July 2017

Mohammad Z

series ordinal

4

1 reference

28 July 2017

publication date

1 August 1999

1 reference

The Journal of Clinical Pharmacology

28 July 2017

published in

1 reference

28 July 2017

volume

39

1 reference

28 July 2017

issue

8

1 reference

28 July 2017

page(s)

767-774

1 reference

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Clinical Pharmacology of Estrogens: Cardiovascular Actions and Cardioprotective Benefits of Replacement Therapy in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Clinical review 27: Effects of hormonal replacement on lipids and lipoproteins in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Estrogen effects on cognition in menopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Menopause and hormone replacement therapy: an overview

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Benefits and risks of estrogen replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effects of tamoxifen treatment on plasma lipids and lipoprotein lipid composition

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Serum cholesterol reduction with tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Agonistic and antagonistic effects of antiestrogens in different target organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Chemoprevention of mammary carcinogenesis in the rat: combined use of raloxifene and 9-cis-retinoic acid.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Molecular basis of agonism and antagonism in the oestrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Hormonal treatment of postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Postmenopausal use of estrogen and occlusion of coronary arteries

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Risk of hospital admission for idiopathic venous thromboembolism among users of postmenopausal oestrogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effects of raloxifene in postmenopausal women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

The decision to enter a randomized trial of tamoxifen for the prevention of breast cancer in healthy women: an analysis of the tradeoffs

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Selective estrogen receptor modulators: a controversial approach for managing postmenopausal health

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Selective estrogen receptor modulators: a look ahead

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Design of the Women’s Health Initiative Clinical Trial and Observational Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

The Use of Estrogens and Progestins and the Risk of Breast Cancer in Postmenopausal Women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Tissue-selective actions of estrogen analogs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Tamoxifen use, oestrogen binding and serum lipids in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Tamoxifen in the treatment of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Designer oestrogens: fact or fantasy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effects of a new antiestrogen, keoxifene (LY156758), on growth of carcinogen-induced mammary tumors and on LH and prolactin levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effects of raloxifene on bone mineral density, serum cholesterol concentrations, and uterine endometrium in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Identification of an estrogen response element activated by metabolites of 17beta-estradiol and raloxifene

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effects of raloxifene on serum lipids and coagulation factors in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Raloxifene inhibits aortic accumulation of cholesterol in ovariectomized, cholesterol-fed rabbits

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Inhibition of LDL oxidation and myeloperoxidase dependent tyrosyl radical formation by the selective estrogen receptor modulator raloxifene (LY139481 HCL)

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effects of tamoxifen on cardiovascular risk factors in postmenopausal women after 5 years of treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effects of the antiestrogen tamoxifen on low-density lipoprotein concentrations and oxidation in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Tamoxifen decreases cholesterol sevenfold and abolishes lipid lesion development in apolipoprotein E knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Effect of tamoxifen on serum cholesterol and lipoproteins during chemohormonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Administration of long-term tamoxifen therapy modifies the plasma lipoprotein-lipid concentration and lipid transfer protein I activity in postmenopausal women with breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Symptoms associated with tamoxifen treatment in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Contrasting effects of conjugated estrogens and tamoxifen on dilator responses of atherosclerotic epicardial coronary arteries in nonhuman primates

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Risk of venous thromboembolism in users of hormone replacement therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Antagonism of estrogen action with a new benzothiophene derived antiestrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

A controlled trial of raloxifene (LY139481) HCl: impact on bone turnover and serum lipid profile in healthy postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Hormone replacement therapy and heart disease prevention: experimentation trumps observation

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

Of designer drugs, magic bullets, and gold standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

SERMs: the benefits of estrogen without the risks?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F00912709922008416

10.1177/00912709922008416

21 January 2018

Identifiers

DOI

1 reference

28 July 2017

1 reference